Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[SAGE] Sage Therapeutics Inc - Gross Profit Margin
Data updated 2023-Sep-10 (Sunday)Note: Detailed Statistics for Gross Profit Margin in Income Statement for Sage Therapeutics Inc [NASDAQ:SAGE] with frequency distribution chart that analyze trends & history . Gross Profit Margin is a profitability metric calculated as Gross Profit / Revenue. View Income Statement for broader context
Share
Quarterly Gross Profit Margin values for Sage Therapeutics Inc are rounded to enhance readability
| 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 78.3% | 83.2% | 84.9% | 73.4% | 68.1% | 64.5% |
| Sequential Quarter Growth | -5.9% | -2.0% | +15.6% | +7.8% | +5.5% | -13.3% |
| Quarter-on Quarter Growth | +15.0% | +28.9% | +14.1% | +16.3% | +88.0% | +186.2% |
Annual Gross Profit Margin values for Sage Therapeutics Inc are rounded to enhance readability
| 2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 75.0% | 75.0% | 33.3% | 99.7% | 57.1% | 98.9% |
| Year-on-Year Growth | 0.0% | +125.0% | -66.6% | +74.5% | -42.2% | |
| 2-yr CAGR | +50.0% | -13.3% | -23.6% | +0.4% | ||
| 3-yr CAGR | -9.1% | +9.5% | -30.4% | |||
| 4-yr CAGR | +7.0% | -6.7% | ||||
| 5-yr CAGR | -5.4% |
Frequency distribution of quarterly Gross Profit Margin values from 2016-Dec-31 grouped into buckets. Latest Gross Profit Margin value is 78.3 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Sage Therapeutics Inc mapped with quarterly Gross Profit Margin values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Gross Profit Margin above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Sage Therapeutics Inc with subsequent post-earnings performance given Gross Profit Margin values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
| Underperform (relative perf.) | Outperform (relative perf.) | |
|---|---|---|
| Gross Profit Margin - Low | 57% | 43% |
| Gross Profit Margin - Medium | 33% | 67% |
| Gross Profit Margin - High | 67% | 33% |
| Gross Profit Margin (Sequential growth %) - Low | 83% | 17% |
| Gross Profit Margin (Sequential growth %) - Medium | 33% | 67% |
| Gross Profit Margin (Sequential growth %) - High | 40% | 60% |
| Gross Profit Margin (QoQ growth %) - Low | 60% | 40% |
| Gross Profit Margin (QoQ growth %) - Medium | 60% | 40% |
| Gross Profit Margin (QoQ growth %) - High | 40% | 60% |
Related to Sage Therapeutics Inc
Information for Sage Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2024-Nov-22 on Google
SEC Reports : Quarterly reports around 2024-Nov-22 on SEC Edgar
Compare Sage Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Sage Therapeutics Inc
Industry : Biotechnology industry performance which includes Sage Therapeutics Inc